Member Info for unvrkw

Sorry Q3 is now and very important and Q4 into USA

Results ok but not amazing I guess. Progress made, reduction in loss and cash in hand. Q4 is xmas and USA pipeline filling of redleg, growth needs to continue to reflect same increasing going forward and they can move forward

Maybe six months from cd4 update and significant next step? We will double the 500k gain at half year from sterling plus announce some contracts? Start selling malaria and pregnancy kits then whoosh on cd4. I think they can get orders quickly, people want the test they just need to prove it is certified

Off the scent! Obviously tomorrow then ?

its loosing some ground these last two days and Q4 to 2017 are the years of where this might start to really improve. some more contracts to sign, a future being created in china and control over budgets as costs start to work towards breakeven. not investing again as yet but now watching

http://trib.al/4YUsCf9

I can't quite work out the trades in the same minute, whether all actual buys or not but some volume. In the past it was never huge volume more just friends of the friend who happens to work for a company called distil! So we know volume should be up, more supermarkets, more exports. Breakeven through just the exchange rate ? Not sure, some pros selling redleg abroad but a big hit bringing it into the uk? Interesting times ahead, hopefully with some progress

I would put money on it. I highlighted it to the CEO that volume increases significantly before RNS updates and you have a leak. He indicated this wasn't the case but it happens every time. Would put money on an update next two days.

The company’s manufacturing facility in Pune, India is set to commence production of malaria and pregnancy test kits in the current financial year. Ahead of this, the company will launch its malaria product range at the forthcoming meeting of the American Society of Tropical Medicine and Hygiene in Atlanta in November. In its food intolerance business, Omega said it had seen particularly strong growth in North America with its microarray-based Foodprint test. The company said it was pursuing further prospects in what it called an attractive consumer-driven market. Omega noted competitive pricing in the infectious disease division with gains in some regions being offset by regional reductions elsewhere as it benefitted from sterling’s weakness . Also everything you would want with sterling. Foreign factory selling in India and money coming home, just like the big drugs companies

"We are pleased with the positive progress that has been made in our key business areas and are looking to the future with increased confidence regarding commercialisation of CD4, the Allersys programme and the Malaria product range." (Andrew Shepherd, Chief Executive Officer) http://bit.ly/2e0c6u5

On the news bulletin it has odx up 17%!! Not quite as yet. Good day and with sterling things will continue. Apart from us and warren buffet no one seems to be happy to wait longer term, all want the fast buck!

good job I went in with the 5k last week as update was more likely next week. so really happy.

that's what I thought when I read the update. a gain from sterling which we thought/knew, around 0.5 million which is never bad to get and extra bonus. all areas stable or improving and some insight into customer deals in USA and for different products. india doing ok, malaria now being promoted and the plant in good order. plus cd4 passing all current tests with no issue and someone brought in to manage the next phase, there was no downside just positive thoughts, structure to the business, improvement aspects and control of what they are doing. good update, couldn't get much better and might now reflect towards the 28 pence target?

Rock and roll dibs, won't buy any more here for at least 2 months so maybe we will have seen a change by then? Gla

Getting some momentum. Gone blue on some stock now, need another 5% to really push through

we normal get an update after end of sept including ebit. not the case so far and might come before tomorrows general meeting to vote the share number change. we knoe revpar is up due to brexit and people staying at home, with this to continue, we know any cash from european franchises will be higher due to sterling. interesting to see where we go next. but 36 million in the bank with 5 hotels identified and i am sure will be highlighted over the next few weeks will be enhancing.

have you been dabbling in again? i bought another 29k shares this morning at 17 so not too bad. will go on the basis good news to come soon ish. gla

Dibs you are really pushing this one which is nice to see. the market for cd4 is already understood. 5 dollars an item, 200 million a year? so the revenue and ebit can be easily understood with very few others in the market and people keen to buy. as we know field tests are in place. I would see if cd4 comes off a significant change in the sp as even a small part of the business would be huge. I quote £1 a share, based on no. shares in play and potential revenue its not impossible. of course if cd4 fails then the future whilst not bust is no where near as rosy.

Would agree, this business model is very much reflective of ftse100 in that the majority of opportunities and earnings can be from abroad

So some can't raise money this week through iPo, however easy hotel got £38 million in the bank from few investors that are long term. Tourism due to Brexit at this time is having a huge affect on volumes and £s spent in the uk which is positive. Longer term we shall see if London gets affected more but budget hotels I would suggest will always do quite well. So cash in the bank for buying properties not working capital and more visitors coming hopefully .